Named the “Hope with Hazel St. Baldrick’s Scholar,” Dr. Michel DuPage will investigate ways to target regulatory T cells (Tregs) as a novel method to enhance immune responses to Neuroblastoma (NB). The Hope with Hazel St.

Here we showed that targeting EZH2 may not only be beneficial in fighting cancer by acting on neoplastic cells, but also by modulating the immune response via disruption of Treg function within cancers.